EXPRESSION OF THE ANTIAPOPTOTIC MCL1 GENE-PRODUCT IS REGULATED BY A MITOGEN-ACTIVATED PROTEIN KINASE-MEDIATED PATHWAY TRIGGERED THROUGH MICROTUBULE DISRUPTION AND PROTEIN-KINASE-C
Kj. Townsend et al., EXPRESSION OF THE ANTIAPOPTOTIC MCL1 GENE-PRODUCT IS REGULATED BY A MITOGEN-ACTIVATED PROTEIN KINASE-MEDIATED PATHWAY TRIGGERED THROUGH MICROTUBULE DISRUPTION AND PROTEIN-KINASE-C, Oncogene, 17(10), 1998, pp. 1223-1234
Members of both the mitogen activated protein (MAP) kinase and BCL2 ge
ne families, acting in concert with other gene products, are involved
in the regulation of cell viability. However, the relationship between
these families, and the signal transduction networks that control via
bility-regulating genes, are only beginning to be elucidated, MCL1 is
a viability-promoting member of the BCL2 family that exhibits a rapid
increase in expression in response to specific differentiation- and ap
optosis-inducing stimuli. The signal transduction pathway involved in
eliciting this increase has now been investigated. In the ML-1 human m
yeloblastic leukemia cell line, a rapid and sustained increase in phos
phorylation of the extracellular signal-regulated kinase (ERK) members
of the MAP kinase family was found to precede the increase in MCL1 ex
pression produced by 12-O-tetradecanoylphorbol 13-acetate (TPA) or the
microtubule-disrupting agents colchicine and vinblastine. ERK activat
ion was necessary for the increase in MCL1, as inhibition of the incre
ase in ERK phosphorylation (with the inhibitor PD 98059) prevented the
increase in MCL1 expression and caused rapid cell death by apoptosis,
In addition, other agents that markedly increased ERK phosphorylation
(lipopolysaccharide, okadaic acid) also increased MCL1 expression. In
contrast, agents that did not have this marked effect did not increas
e MCL1, Upstream components in this ERK-mediated pathway were also ide
ntified, where the pathway was found to be stimulated by microtubule d
isruption acting through protein kinase C (PKC). These results indicat
e that expression of the MCL1 viability-enhancing gene is regulated th
rough a cytoskeletal disruption-induced ERK-mediated signal, transduct
ion pathway. They therefore suggest a mechanism through which the cyto
skeleton and MAP kinases can exert effects on cell viability.